ENDRA Life Sciences (NASDAQ:NDRA) Announces Earnings Results, Misses Expectations By $5.30 EPS

ENDRA Life Sciences (NASDAQ:NDRA) announced its earnings results on Monday. The company reported ($9.40) EPS for the quarter, missing the consensus estimate of ($4.10) by ($5.30), Zacks reports.

ENDRA Life Sciences Trading Up 4.6 %

Shares of ENDRA Life Sciences stock traded up $0.19 during trading hours on Monday, reaching $4.24. 2,274 shares of the company’s stock were exchanged, compared to its average volume of 99,368. The company has a 50 day moving average of $4.63 and a two-hundred day moving average of $5.97. ENDRA Life Sciences has a fifty-two week low of $3.15 and a fifty-two week high of $875.00. The stock has a market cap of $2.27 million, a P/E ratio of 0.00 and a beta of 0.43.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.